N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer
Open Access
- 23 August 2023
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 14 (8) , 1-12
Abstract
KIAA1324 is a transmembrane protein largely reported as a tumor suppressor and favorable prognosis marker in various cancers, including gastric cancer. In this study, we report the role of N-linked glycosylation in KIAA1324 as a functional post-translational modification (PTM). Loss of N-linked glycosylation eliminated the potential of KIAA1324 to suppress cancer cell proliferation and migration. Furthermore, we demonstrated that KIAA1324 undergoes fucosylation, a modification of the N-glycan mediated by fucosyltransferase, and inhibition of fucosylation also significantly suppressed KIAA1324-induced cell growth inhibition and apoptosis of gastric cancer cells. In addition, KIAA1324-mediated apoptosis and tumor regression were inhibited by the loss of N-linked glycosylation. RNA sequencing (RNAseq) analysis revealed that genes most relevant to the apoptosis and cell cycle arrest pathways were modulated by KIAA1324 with the N-linked glycosylation, and Gene Regulatory Network (GRN) analysis suggested novel targets of KIAA1324 for anti-tumor effects in the transcription level. The N-linked glycosylation blockade decreased protein stability through rapid proteasomal degradation. The non-glycosylated mutant also showed altered localization and lost apoptotic activity that inhibits the interaction between GRP78 and caspase 7. These data demonstrate that N-linked glycosylation of KIAA1324 is essential for the suppressive role of KIAA1324 protein in gastric cancer progression and indicates that KIAA1324 may have anti-tumor effects by targeting cancer-related genes with N-linked glycosylation. In conclusion, our study suggests the PTM of KIAA1324 including N-linked glycosylation and fucosylation is a necessary factor to consider for cancer prognosis and therapy improvement.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (2015R1C1A1A01054727, 2021M3H9A2096988, 2015R1D1A1A01057623)
- Korea Health Industry Development Institute (HA17C0037)
- Ministry of Health and Welfare (HI14C2640)
This publication has 50 references indexed in Scilit:
- SignaLink 2 – a signaling pathway resource with multi-layered regulatory networksBMC Systems Biology, 2013
- Differential analysis of gene regulation at transcript resolution with RNA-seqNature Biotechnology, 2012
- Architecture of the human regulatory network derived from ENCODE dataNature, 2012
- TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptorBiochemical Journal, 2012
- Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targetingBiochemical Journal, 2011
- Orphan nuclear receptors in breast cancer pathogenesis and therapeutic responseEndocrine-Related Cancer, 2010
- The novel estrogen-induced gene EIG121 regulates autophagy and promotes cell survival under stressCell Death & Disease, 2010
- JNK signaling in apoptosisOncogene, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase InhibitorsJournal of Biological Chemistry, 2003